Janardan Khandekar to Adenocarcinoma
This is a "connection" page, showing publications Janardan Khandekar has written about Adenocarcinoma.
Connection Strength
0.090
-
Endometrial carcinoma following estrogen therapy for breast cancer. Report of three cases. Arch Intern Med. 1978 Apr; 138(4):539-41.
Score: 0.021
-
High-dose aminothiadiazole in advanced colorectal cancer. An Illinois Cancer Center phase II trial. Invest New Drugs. 1994; 12(4):299-301.
Score: 0.016
-
Phase II trial of continuous drug infusions in advanced ovarian carcinoma: acivicin versus vinblastine. Invest New Drugs. 1989 Jul; 7(2-3):255-60.
Score: 0.011
-
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer. Cancer. 1985 Aug 01; 56(3):457-60.
Score: 0.009
-
A randomized study of low and high doses of leukocyte alpha-interferon in metastatic renal cell carcinoma: the American Cancer Society collaborative trial. Cancer Res. 1985 Feb; 45(2):863-71.
Score: 0.008
-
Phase II trial of mitolactol in previously treated and untreated patients with advanced colorectal cancer: an Illinois Cancer Council trial. Cancer Treat Rep. 1984 Oct; 68(10):1303-4.
Score: 0.008
-
Effect of interferon therapy on indomethacin-sensitive immunoregulation in the peripheral blood mononuclear cells of renal cell carcinoma patients. J Biol Response Mod. 1983; 2(3):251-62.
Score: 0.007
-
A randomized comparison of two dosage schedules of methyl CCNU: three-week versus six-week treatments. Cancer. 1979 Sep; 44(3):824-30.
Score: 0.006
-
Hepatic fine structural changes and microsomal hypofunction in Walker tumor-bearing rats. Cancer. 1972 Mar; 29(3):738-43.
Score: 0.003